FLT3 and leukemia: Interestingly, all three AML patients who harbored FLT-3 internal tandem duplication (ITD) mutations, a prognostic marker in AML with poor prognosis [10], were able to lyse leukemia containing CD3-cell fractions following allogeneic stimulation.